Surgery for advanced hepatocellular carcinoma: Time to take action

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|112|8|909-909

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.112, Iss.8, 2015-12, pp. : 909-909

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypertension in Pakistan: time to take some serious action

By Saleem Fahad   Hassali Azmi Ahmad   Shafie Asrul Akmal  

British Journal of General Practice, Vol. 60, Iss. 575, 2010-06 ,pp. : 449-450

Royal College of General Practitioners

Access to resources Recommend Favorite

Deconvolution of the cellular origin in hepatocellular carcinoma: Hepatocytes take the center stage

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1020-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low-Dose Thalidomide Treatment for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 242-249

Karger

Access to resources Recommend Favorite

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Predictors of non-adherence to systemic oral therapy for advanced hepatocellular carcinoma

By Mallick Rajiv   Cai Jennifer   Wogen Jenifer  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1701-1708

Informa Healthcare

Access to resources Recommend Favorite